Looking good for NUZ001 then, especially starting treatment earlier
VERY good, I would suggest. We've already nailed survival as per the Ph1 and OLE, and performed brilliantly against the ALSFRS scores. I don't know if we previously measured respiratory function, but I would think that against the backdrop of excellent ALSFRS scoring, that'd have to be positive also. And cap that off with an early start for patients on their ALS journey - very encouraging!
The Ph2 results after 9-months of trialling should be exceptionally compelling!
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)